We are live on ! Find out more
CF

Corebridge Financial Portfolio holdings

AUM $4.25M
1-Year Est. Return 33.15%
This Fund
S&P 500
This Quarter Est. Return
-3.26%
1 Year Est. Return
-33.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$17.4B
AUM Growth
-$1.11B
Cap. Flow
-$117M
Cap. Flow %
-0.67%
Top 10 Hldgs %
25.42%
Holding
3,045
New
14
Increased
313
Reduced
2,663
Closed
30

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$39.3M
2
NVDA icon
NVIDIA
NVDA
+$38.8M
3
AAPL icon
Apple
AAPL
+$36.4M
4
WSM icon
Williams-Sonoma
WSM
+$21.8M
5
EXE
Expand Energy Corp
EXE
+$19.7M

Sector Composition

Rank Sector Weight
1 Technology 26.79%
2 Financials 13.87%
3 Consumer Discretionary 10.73%
4 Healthcare 10.45%
5 Industrials 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATOS icon
2776
Atossa Therapeutics
ATOS
$25M
$41.7K ﹤0.01%
4,131
-61
-1% -$741
APLS
2777
DELISTED
Apellis Pharmaceuticals
APLS
$41.6K ﹤0.01%
1,901
-24
-1% -$663
EGAN icon
2778
eGain
EGAN
$138M
$41.6K ﹤0.01%
8,569
-127
-1% -$719
GPRO icon
2779
GoPro
GPRO
$285M
$41.4K ﹤0.01%
62,513
+289
+0.5% +$255
LOAR icon
2780
Loar Holdings
LOAR
$6.23B
$41.4K ﹤0.01%
586
+62
+12% +$4.47K
TWIN icon
2781
Twin Disc
TWIN
$357M
$41.4K ﹤0.01%
5,469
-80
-1% -$777
LEG
2782
DELISTED
Leggett & Platt
LEG
$41.4K ﹤0.01%
5,233
-425
-8% -$4.03K
COLD icon
2783
Americold
COLD
$4.17B
$41K ﹤0.01%
1,912
-63
-3% -$1.37K
MBX
2784
MBX Biosciences
MBX
$2.84B
$40.7K ﹤0.01%
5,511
-82
-1% -$867
NTIC icon
2785
Northern Technologies International Corp
NTIC
$77.1M
$40.1K ﹤0.01%
3,855
-58
-1% -$680
LXEO icon
2786
Lexeo Therapeutics
LXEO
$349M
$40.1K ﹤0.01%
11,544
-171
-1% -$758
IRBT
2787
DELISTED
iRobot
IRBT
$40K ﹤0.01%
14,810
-59
-0.4% -$426
RITM icon
2788
Rithm Capital
RITM
$5.44B
$40K ﹤0.01%
3,490
-114
-3% -$1.32K
SPCE icon
2789
Virgin Galactic
SPCE
$443M
$39.9K ﹤0.01%
13,158
-14
-0.1% -$61
LCTX icon
2790
Lineage Cell Therapeutics
LCTX
$255M
$39.7K ﹤0.01%
87,955
+14,506
+20% +$8.51K
RILY icon
2791
BRC Group Holdings
RILY
$265M
$39.2K ﹤0.01%
10,118
-29
-0.3% -$132
FATE icon
2792
Fate Therapeutics
FATE
$277M
$38.8K ﹤0.01%
49,045
-727
-1% -$891
CWEN.A
2793
DELISTED
Clearway Energy Class A
CWEN.A
$38.4K ﹤0.01%
1,350
-111
-8% -$2.85K
MGNX icon
2794
MacroGenics
MGNX
$255M
$38.2K ﹤0.01%
30,112
-446
-1% -$1.17K
TPG icon
2795
TPG
TPG
$7.95B
$38.1K ﹤0.01%
804
-19
-2% -$1.11K
CDLX icon
2796
Cardlytics
CDLX
$24.4M
$37.8K ﹤0.01%
2,075
+10
+0.5% +$286
PLRX icon
2797
Pliant Therapeutics
PLRX
$72.4M
$37.7K ﹤0.01%
27,915
-414
-1% -$2.51K
THRD
2798
DELISTED
Third Harmonic Bio
THRD
$37.3K ﹤0.01%
10,739
+882
+9% +$4.28K
OMF icon
2799
OneMain Financial
OMF
$7.22B
$37.1K ﹤0.01%
760
-24
-3% -$1.27K
CRBU icon
2800
Caribou Biosciences
CRBU
$136M
$36.8K ﹤0.01%
40,304
-597
-1% -$776

Similar funds

Corebridge Financial's Q1 2025 Portfolio in Review

As of Q1 2025, Corebridge Financial held 3,045 positions worth $17.4B, down 6% from $18.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 1.4%. Corebridge Financial opened 14 new positions and exited 30, leaving the 3,045-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Corebridge Financial's largest Q1 2025 buy was State Street Blackstone Senior Loan ETF: 9,585,037 shares worth $394M.
  • Corebridge Financial added most to State Street SPDR Portfolio S&P 500 Growth ETF in Q1 2025, an estimated $19.5M increase.
  • Corebridge Financial's biggest Q1 2025 reduction was Microsoft, cutting an estimated $39.3M.
  • Corebridge Financial fully exited iShares Core S&P 500 ETF in Q1 2025, selling an estimated $10.6M.
  • Corebridge Financial's ten largest holdings make up 25% of its $17.4B portfolio in Q1 2025.
  • Corebridge Financial opened 14 new positions and closed 30 in Q1 2025.
  • Corebridge Financial's portfolio value fell 6% quarter-over-quarter to $17.4B.

Based on Corebridge Financial's 13F filing for Q1 2025, filed 14 May 2025.